To date, datasets have been released for cells treated with a broad range of perturbations, including siRNA and CRISPR/Cas9 genetic knockdown/knockout, small molecules at multiple concentrations, SARS-CoV-2 virus, immune-focused proteins, and a model of COVID-19 cytokine storm.
Our publicly available datasets represent less than 1% of Recursion’s full,
proprietary dataset. Interested in partnering with us commercially?